These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16859306)

  • 21. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
    Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A
    Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust Bayesian clustering.
    Archambeau C; Verleysen M
    Neural Netw; 2007 Jan; 20(1):129-38. PubMed ID: 17011164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brownian and essential dynamics studies of the HIV-1 integrase catalytic domain.
    Weber W; Demirdjian H; Lins RD; Briggs JM; Ferreira R; McCammon JA
    J Biomol Struct Dyn; 1998 Dec; 16(3):733-45. PubMed ID: 10052629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor.
    Vandurm P; Cauvin C; Guiguen A; Georges B; Le Van K; Martinelli V; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4806-9. PubMed ID: 19556126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexes of HIV-1 integrase with HAT proteins: multiscale models, dynamics, and hypotheses on allosteric sites of inhibition.
    Di Fenza A; Rocchia W; Tozzini V
    Proteins; 2009 Sep; 76(4):946-58. PubMed ID: 19306343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the interactions between HIV-1 integrase and human LEDGF/p75 by molecular dynamics simulation and free energy calculation.
    Zhao Y; Li W; Zeng J; Liu G; Tang Y
    Proteins; 2008 Aug; 72(2):635-45. PubMed ID: 18247352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient computation of confidence intervals for Bayesian model predictions based on multidimensional parameter space.
    Smith AD; Genz A; Freiberger DM; Belenky G; Van Dongen HP
    Methods Enzymol; 2009; 454():213-31. PubMed ID: 19216928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of a Gibbs sampler method for model-based clustering of gene expression data.
    Joshi A; Van de Peer Y; Michoel T
    Bioinformatics; 2008 Jan; 24(2):176-83. PubMed ID: 18033794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying and correcting non-Markov states in peptide conformational dynamics.
    Nerukh D; Jensen CH; Glen RC
    J Chem Phys; 2010 Feb; 132(8):084104. PubMed ID: 20192287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain.
    Brigo A; Lee KW; Iurcu Mustata G; Briggs JM
    Biophys J; 2005 May; 88(5):3072-82. PubMed ID: 15764656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of peptide conformational dynamics on clustering of a classical molecular dynamics trajectory.
    Jensen CH; Nerukh D; Glen RC
    J Chem Phys; 2008 Mar; 128(11):115107. PubMed ID: 18361622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clustering of change patterns using Fourier coefficients.
    Kim J; Kim H
    Bioinformatics; 2008 Jan; 24(2):184-91. PubMed ID: 18025003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of binding parameters of HIV-1 integrase inhibitors: correlates of drug inhibition and resistance.
    Loizidou EZ; Zeinalipour-Yazdi CD; Christofides T; Kostrikis LG
    Bioorg Med Chem; 2009 Jul; 17(13):4806-18. PubMed ID: 19450984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LEGClust- a clustering algorithm based on layered entropic subgraphs.
    Santos JM; Marques de Sa J; Alexandre LA
    IEEE Trans Pattern Anal Mach Intell; 2008 Jan; 30(1):62-75. PubMed ID: 18000325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors.
    Langley DR; Samanta HK; Lin Z; Walker MA; Krystal MR; Dicker IB
    Biochemistry; 2008 Dec; 47(51):13481-8. PubMed ID: 18991395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian detection of intensity changes in single molecule and molecular dynamics trajectories.
    Ensign DL; Pande VS
    J Phys Chem B; 2010 Jan; 114(1):280-92. PubMed ID: 20000829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on the molecular mechanism of inhibiting HIV-1 integrase by EBR28 peptide via molecular modeling approach.
    Hu JP; Gong XQ; Su JG; Chen WZ; Wang CX
    Biophys Chem; 2008 Feb; 132(2-3):69-80. PubMed ID: 18037557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on the inhibitory mechanism and binding mode of the hydroxycoumarin compound NSC158393 to HIV-1 integrase by molecular modeling.
    Liu M; Cong XJ; Li P; Tan JJ; Chen WZ; Wang CX
    Biopolymers; 2009 Sep; 91(9):700-9. PubMed ID: 19382173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
    Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.